Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Structure-based classification of class A beta-lactamases, an update.

Philippon A, Jacquier H, Ruppé E, Labia R.

Curr Res Transl Med. 2019 May 31. pii: S2452-3186(19)30021-2. doi: 10.1016/j.retram.2019.05.003. [Epub ahead of print] Review.

PMID:
31155436
2.

A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Philippon A, Slama P, Dény P, Labia R.

Clin Microbiol Rev. 2016 Jan;29(1):29-57. doi: 10.1128/CMR.00019-15. Review.

3.

A new mechanism to render clinical isolates of Escherichia coli non-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domain.

Aissa N, Mayer N, Bert F, Labia R, Lozniewski A, Nicolas-Chanoine MH.

J Antimicrob Chemother. 2016 Jan;71(1):76-9. doi: 10.1093/jac/dkv318. Epub 2015 Oct 12.

PMID:
26462991
4.

New syntheses and potential antimalarial activities of new 'retinoid-like chalcones'.

Valla A, Valla B, Cartier D, Le Guillou R, Labia R, Florent L, Charneau S, Schrevel J, Potier P.

Eur J Med Chem. 2006 Jan;41(1):142-6. Epub 2005 Nov 7.

PMID:
16274873
5.

Syntheses, in vitro antibacterial and antifungal activities of a series of N-alkyl, 1,4-dithiines.

Zentz F, Labia R, Sirot D, Faure O, Grillot R, Valla A.

Farmaco. 2005 Nov-Dec;60(11-12):944-7. Epub 2005 Oct 18.

PMID:
16239002
6.

Survey of Enterobacteriaceae producing extended-spectrum beta-lactamases in a Slovak hospital: dominance of SHV-2a and characterization of TEM-132.

Zarnayová M, Siebor E, Péchinot A, Duez JM, Bujdáková H, Labia R, Neuwirth C.

Antimicrob Agents Chemother. 2005 Jul;49(7):3066-9.

7.

Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC beta-lactamase of a Serratia marcescens clinical isolate.

Hidri N, Barnaud G, Decré D, Cerceau C, Lalande V, Petit JC, Labia R, Arlet G.

J Antimicrob Chemother. 2005 Apr;55(4):496-9. Epub 2005 Feb 18.

PMID:
15722393
8.

Syntheses, in vitro antibacterial and cytotoxic activities of a series of 3-substituted succinimides.

Zentz F, Le Guillou R, Labia R, Sirot D, Linard B, Valla A.

Farmaco. 2004 Nov;59(11):879-86.

PMID:
15544792
9.

Structure-activity relationships of methylene or terminal side chain modified retinoids on the differentiation and cell death signaling in NB4 promyelocytic leukemia cells.

Ivanova D, Rossin A, Gronemeyer H, Valla A, Cartier D, Le Guillou R, Labia R.

Bioorg Med Chem Lett. 2004 Aug 16;14(16):4257-61.

PMID:
15261282
10.

Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate.

Barnaud G, Benzerara Y, Gravisse J, Raskine L, Sanson-Le Pors MJ, Labia R, Arlet G.

Antimicrob Agents Chemother. 2004 Mar;48(3):1040-2.

11.

Antifouling activities of N-substituted imides: antimicrobial activities and inhibition of Mytilus edulis phenoloxidase.

Zentz F, Hellio C, Valla A, De La Broise D, Bremer G, Labia R.

Mar Biotechnol (NY). 2002 Sep;4(4):431-40.

PMID:
14961255
12.

Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9.

Aumeran C, Chanal C, Labia R, Sirot D, Sirot J, Bonnet R.

Antimicrob Agents Chemother. 2003 Sep;47(9):2958-61.

13.

Molecular and biochemical characterization of a novel class A beta-lactamase (HER-1) from Escherichia hermannii.

Beauchef-Havard A, Arlet G, Gautier V, Labia R, Grimont P, Philippon A.

Antimicrob Agents Chemother. 2003 Aug;47(8):2669-73.

14.
15.

First isolation of CTX-M15-producing Escherichia coli from two French patients.

Neuwirth C, Siebor E, Pruneaux M, Zarnayova M, Simonin C, Kisterman JP, Labia R.

J Antimicrob Chemother. 2003 Feb;51(2):471-3. No abstract available.

PMID:
12562730
16.

Biochemical-genetic analysis and distribution of DES-1, an Ambler class A extended-spectrum beta-lactamase from Desulfovibrio desulfuricans.

Morin AS, Poirel L, Mory F, Labia R, Nordmann P.

Antimicrob Agents Chemother. 2002 Oct;46(10):3215-22.

17.

Beta-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types.

Humeniuk C, Arlet G, Gautier V, Grimont P, Labia R, Philippon A.

Antimicrob Agents Chemother. 2002 Sep;46(9):3045-9.

18.

BUT-1: a new member in the chromosomal inducible class C beta-lactamases family from a clinical isolate of Buttiauxella sp.

Fihman V, Rottman M, Benzerara Y, Delisle F, Labia R, Philippon A, Arlet G.

FEMS Microbiol Lett. 2002 Jul 16;213(1):103-11.

19.

Novel plasmid-encoded class C beta-lactamase (MOX-2) in Klebsiella pneumoniae from Greece.

Raskine L, Borrel I, Barnaud G, Boyer S, Hanau-Berçot B, Gravisse J, Labia R, Arlet G, Sanson-Le-Pors MJ.

Antimicrob Agents Chemother. 2002 Jul;46(7):2262-5.

20.

Synthesis and antimicrobial activities of N-substituted imides.

Zentz F, Valla A, Le Guillou R, Labia R, Mathot AG, Sirot D.

Farmaco. 2002 May;57(5):421-6.

PMID:
12058815
21.

Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.

Madec S, Blin C, Krishnamoorthy R, Picard B, Chaibi el B, Fouchereau-Péron M, Labia R.

FEMS Microbiol Lett. 2002 May 21;211(1):13-6.

22.

Chromosome-encoded class D beta-lactamase OXA-23 in Proteus mirabilis.

Bonnet R, Marchandin H, Chanal C, Sirot D, Labia R, De Champs C, Jumas-Bilak E, Sirot J.

Antimicrob Agents Chemother. 2002 Jun;46(6):2004-6.

23.

TEM-80, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Enterobacter cloacae.

Arpin C, Labia R, Dubois V, Noury P, Souquet M, Quentin C.

Antimicrob Agents Chemother. 2002 May;46(5):1183-9.

24.

Bacterial and epidemiologic study of the resistance to oxyiminocephalosporins in Escherichia coli in a French hospital.

Lepelletier D, Orsonneau JL, Blin A, Labia R, Richet H, Reynaud A.

Clin Microbiol Infect. 1999 Jan;5(1):37-46.

25.
26.

Antimicrobial susceptibility test: from bacterial population analysis to therapy.

Scavizzi MR, Labia R, Petitjean OJ, Elbhar A.

Int J Antimicrob Agents. 2002 Jan;19(1):9-20.

PMID:
11814763
27.
28.

TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.

Neuwirth C, Madec S, Siebor E, Pechinot A, Duez JM, Pruneaux M, Fouchereau-Peron M, Kazmierczak A, Labia R.

Antimicrob Agents Chemother. 2001 Dec;45(12):3591-4.

29.

Antimicrobial susceptibilities of clinical Desulfovibrio isolates.

Lozniewski A, Labia R, Haristoy X, Mory F.

Antimicrob Agents Chemother. 2001 Oct;45(10):2933-5.

30.

SHV-16, a beta-lactamase with a pentapeptide duplication in the omega loop.

Arpin C, Labia R, Andre C, Frigo C, El Harrif Z, Quentin C.

Antimicrob Agents Chemother. 2001 Sep;45(9):2480-5.

31.

Cloning and biochemical characterization of a class A beta-lactamase from Prevotella intermedia.

Madinier I, Fosse T, Giudicelli J, Labia R.

Antimicrob Agents Chemother. 2001 Aug;45(8):2386-9.

32.

Molecular characterization of chromosomal class C beta-lactamase and its regulatory gene in Ochrobactrum anthropi.

Nadjar D, Labia R, Cerceau C, Bizet C, Philippon A, Arlet G.

Antimicrob Agents Chemother. 2001 Aug;45(8):2324-30.

33.

Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.

Bonnet R, Dutour C, Sampaio JL, Chanal C, Sirot D, Labia R, De Champs C, Sirot J.

Antimicrob Agents Chemother. 2001 Aug;45(8):2269-75.

34.

Evidence of in vivo transfer of a plasmid encoding the extended-spectrum beta-lactamase TEM-24 and other resistance factors among different members of the family Enterobacteriaceae.

Neuwirth C, Siebor E, Pechinot A, Duez JM, Pruneaux M, Garel F, Kazmierczak A, Labia R.

J Clin Microbiol. 2001 May;39(5):1985-8.

35.

Molecular and biochemical analysis of AST-1, a class A beta-lactamase from Nocardia asteroides sensu stricto.

Poirel L, Laurent F, Naas T, Labia R, Boiron P, Nordmann P.

Antimicrob Agents Chemother. 2001 Mar;45(3):878-82.

36.
37.

A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil.

Bonnet R, Sampaio JL, Chanal C, Sirot D, De Champs C, Viallard JL, Labia R, Sirot J.

Antimicrob Agents Chemother. 2000 Nov;44(11):3061-8.

38.

A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil.

Bonnet R, Sampaio JL, Labia R, De Champs C, Sirot D, Chanal C, Sirot J.

Antimicrob Agents Chemother. 2000 Jul;44(7):1936-42.

39.

Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital.

Chanal C, Bonnet R, De Champs C, Sirot D, Labia R, Sirot J.

Antimicrob Agents Chemother. 2000 Jul;44(7):1930-5.

40.

Characterization of TEM-56, a novel beta-lactamase produced by a Klebsiella pneumoniae clinical isolate.

Neuwirth C, Labia R, Siebor E, Pechinot A, Madec S, Chaibi EB, Kazmierczak A.

Antimicrob Agents Chemother. 2000 Feb;44(2):453-5.

41.

Analysis of the bla(toho) gene coding for Toho-2-beta-lactamase.

Labia R.

Antimicrob Agents Chemother. 1999 Oct;43(10):2576-7. No abstract available.

42.

Diversity of TEM mutants in Proteus mirabilis.

Bonnet R, De Champs C, Sirot D, Chanal C, Labia R, Sirot J.

Antimicrob Agents Chemother. 1999 Nov;43(11):2671-7.

43.

Synthesis of pyrazolidinone antibacterial agents.

Couloigner E, Cartier D, Labia R.

Bioorg Med Chem Lett. 1999 Aug 2;9(15):2205-6.

PMID:
10465546
44.

Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytoca.

Bermudes H, Jude F, Chaibi EB, Arpin C, Bebear C, Labia R, Quentin C.

Antimicrob Agents Chemother. 1999 Jul;43(7):1657-61.

45.

Biochemical-genetic analysis and distribution of FAR-1, a class A beta-lactamase from Nocardia farcinica.

Laurent F, Poirel L, Naas T, Chaibi EB, Labia R, Boiron P, Nordmann P.

Antimicrob Agents Chemother. 1999 Jul;43(7):1644-50.

46.

Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.

Chaïbi EB, Sirot D, Paul G, Labia R.

J Antimicrob Chemother. 1999 Apr;43(4):447-58. Review.

PMID:
10350372
47.

Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene.

Poirel L, Naas T, Guibert M, Chaibi EB, Labia R, Nordmann P.

Antimicrob Agents Chemother. 1999 Mar;43(3):573-81.

48.

Inhibitor-resistant TEM beta-lactamases: revision of the TEM-41 sequence.

Labia R, Chaibi EB, Sirot D, Chanal-Claris C, Stapleton P, Shannon K, French G.

Antimicrob Agents Chemother. 1998 Oct;42(10):2771. No abstract available.

49.

X-ray analysis of the NMC-A beta-lactamase at 1.64-A resolution, a class A carbapenemase with broad substrate specificity.

Swarén P, Maveyraud L, Raquet X, Cabantous S, Duez C, Pédelacq JD, Mariotte-Boyer S, Mourey L, Labia R, Nicolas-Chanoine MH, Nordmann P, Frère JM, Samama JP.

J Biol Chem. 1998 Oct 9;273(41):26714-21.

50.

Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.

Sirot D, Labia R, Pouedras P, Chanal-Claris C, Cerceau C, Sirot J.

Antimicrob Agents Chemother. 1998 Sep;42(9):2184-7.

Supplemental Content

Support Center